AbbVie buys Celsius Therapeutics for $250 million

Jun 27, 2024, 4:06 PM•crainalerts

AbbVie buys Celsius Therapeutics for 0 million

Having trouble viewing this email? See the online version

Health Pulse Breaking News

Thursday, June 27, 2024

Sign outside of AbbVie's North Chicago headquarters

AbbVie buys drug developer Celsius Therapeutics for $250 million

AbbVie is counting on the Cambridge-based biotech to further beef up its arsenal of drugs to fight Crohn's disease and ulcerative colitis.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

VIEW OUR SUBSCRIPTION OFFERS

This email was sent to -
Manage My Account | Contact Us

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

Latest Emails from crainalerts

crainalerts

Fri 9:16 PM

A rare win for the downtown office market just got bigger

͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏

Read full newsletter →

crainalerts

Fri 8:06 PM

Billions on the line with Trump pot order

Catch up on today's top stories. ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌

Read full newsletter →

crainalerts

Fri 7:00 PM

Tax sweeteners need reworking: study

Read full newsletter →

crainalerts

Fri 6:28 PM

Winston & Strawn in merger talks with UK firm

Read full newsletter →

crainalerts

Fri 6:01 PM

Chicago hospital execs signal trouble in 2026: Crain's Daily Gist week in review

Read full newsletter →

crainalerts

Fri 4:47 PM

Pritzker signs 'medical aid in dying' bill

Read full newsletter →

crainalerts

Fri 12:03 PM

Property tax perks poised for an overhaul

Here are this morning's top stories. ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌ ͏ ‌